Global NAD+ Health Products Supply, Demand and Key Producers, 2026-2032
The global NAD+ Health Products market size is expected to reach $ 1544 million by 2032, rising at a market growth of 14.8% CAGR during the forecast period (2026-2032).
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.
Strong Market Growth Driven by Aging Population and Longevity Demand
The NAD+ booster capsule market is expected to maintain strong growth as global populations age and consumer awareness of longevity, cellular health, and metabolic wellness increases. Capsules remain the most commercially scalable and accessible format, making them the preferred product type for retail brands. Demand is expanding rapidly in North America, Europe, Japan, and China, driven by rising interest in anti-aging science and the shift toward preventive healthcare.
Scientific Validation and Ingredient Innovation Accelerate Adoption
Future development will be shaped by increasing clinical research on NMN, NR, and other NAD+ precursors, which is improving consumer trust and regulatory acceptance. Innovation in stabilization technology, sustained-release capsules, and enhanced-bioavailability formulations (such as liposomal or microencapsulated NAD+ boosters) is expected to differentiate brands and raise product efficacy. Companies are also developing novel precursor combinations to expand the biological pathways for NAD+ synthesis.
Regulatory Standardization and Quality Compliance Will Become Critical
As NAD+ boosters gain popularity, more stringent global regulations are emerging to ensure safety, purity, and label accuracy?especially in the U.S., EU, and China. The industry is shifting toward pharmaceutical-grade manufacturing, third-party testing, and validated human trials. Brands able to meet future compliance standards and provide transparent clinical data will dominate premium segments, while lower-quality manufacturers may be pressured out of the market.
Expansion into Personalized Nutrition and Integrated Health Ecosystems
Future growth will increasingly come from personalized supplementation, digital health integration, and subscription-based models. NAD+ booster capsules will be combined with biomarker testing, mitochondrial support formulas, gut-health products, and AI-driven health monitoring platforms. Partnerships with longevity clinics, anti-aging centers, and wellness programs will help capsules evolve from stand-alone supplements into components of broader metabolic and cellular-health ecosystems.
This report studies the global NAD+ Health Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for NAD+ Health Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of NAD+ Health Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global NAD+ Health Products total market, 2021-2032, (USD Million)
Global NAD+ Health Products total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: NAD+ Health Products total market, key domestic companies, and share, (USD Million)
Global NAD+ Health Products revenue by player, revenue and market share 2021-2026, (USD Million)
Global NAD+ Health Products total market by Type, CAGR, 2021-2032, (USD Million)
Global NAD+ Health Products total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global NAD+ Health Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world NAD+ Health Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global NAD+ Health Products Market, By Region:
1. How big is the global NAD+ Health Products market?
2. What is the demand of the global NAD+ Health Products market?
3. What is the year over year growth of the global NAD+ Health Products market?
4. What is the total value of the global NAD+ Health Products market?
5. Who are the Major Players in the global NAD+ Health Products market?
6. What are the growth factors driving the market demand?
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.
Strong Market Growth Driven by Aging Population and Longevity Demand
The NAD+ booster capsule market is expected to maintain strong growth as global populations age and consumer awareness of longevity, cellular health, and metabolic wellness increases. Capsules remain the most commercially scalable and accessible format, making them the preferred product type for retail brands. Demand is expanding rapidly in North America, Europe, Japan, and China, driven by rising interest in anti-aging science and the shift toward preventive healthcare.
Scientific Validation and Ingredient Innovation Accelerate Adoption
Future development will be shaped by increasing clinical research on NMN, NR, and other NAD+ precursors, which is improving consumer trust and regulatory acceptance. Innovation in stabilization technology, sustained-release capsules, and enhanced-bioavailability formulations (such as liposomal or microencapsulated NAD+ boosters) is expected to differentiate brands and raise product efficacy. Companies are also developing novel precursor combinations to expand the biological pathways for NAD+ synthesis.
Regulatory Standardization and Quality Compliance Will Become Critical
As NAD+ boosters gain popularity, more stringent global regulations are emerging to ensure safety, purity, and label accuracy?especially in the U.S., EU, and China. The industry is shifting toward pharmaceutical-grade manufacturing, third-party testing, and validated human trials. Brands able to meet future compliance standards and provide transparent clinical data will dominate premium segments, while lower-quality manufacturers may be pressured out of the market.
Expansion into Personalized Nutrition and Integrated Health Ecosystems
Future growth will increasingly come from personalized supplementation, digital health integration, and subscription-based models. NAD+ booster capsules will be combined with biomarker testing, mitochondrial support formulas, gut-health products, and AI-driven health monitoring platforms. Partnerships with longevity clinics, anti-aging centers, and wellness programs will help capsules evolve from stand-alone supplements into components of broader metabolic and cellular-health ecosystems.
This report studies the global NAD+ Health Products demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for NAD+ Health Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of NAD+ Health Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global NAD+ Health Products total market, 2021-2032, (USD Million)
Global NAD+ Health Products total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: NAD+ Health Products total market, key domestic companies, and share, (USD Million)
Global NAD+ Health Products revenue by player, revenue and market share 2021-2026, (USD Million)
Global NAD+ Health Products total market by Type, CAGR, 2021-2032, (USD Million)
Global NAD+ Health Products total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global NAD+ Health Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Niagen Bioscience, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world NAD+ Health Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global NAD+ Health Products Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- NMNContent ?98%
- NMNContent ?98%
- Powder
- Liquid
- Others
- Oral Type
- Non-oral Type
- Health Care Products
- Beauty Products
- Others
- GeneHarbor
- Niagen Bioscience
- Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- Herbalmax
- EffePharm
- Kingdomway
- NOMON Co., Ltd. (Teijin)
- CELFULL
- Bontac
- Genex Formulas
- EZZ
- Maac10 Formulas
- Elysium Health
1. How big is the global NAD+ Health Products market?
2. What is the demand of the global NAD+ Health Products market?
3. What is the year over year growth of the global NAD+ Health Products market?
4. What is the total value of the global NAD+ Health Products market?
5. Who are the Major Players in the global NAD+ Health Products market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 NAD+ Health Products Introduction
1.2 World NAD+ Health Products Market Size & Forecast (2021 & 2025 & 2032)
1.3 World NAD+ Health Products Total Market by Region (by Headquarter Location)
1.3.1 World NAD+ Health Products Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company NAD+ Health Products Revenue (2021-2032)
1.3.3 China Based Company NAD+ Health Products Revenue (2021-2032)
1.3.4 Europe Based Company NAD+ Health Products Revenue (2021-2032)
1.3.5 Japan Based Company NAD+ Health Products Revenue (2021-2032)
1.3.6 South Korea Based Company NAD+ Health Products Revenue (2021-2032)
1.3.7 ASEAN Based Company NAD+ Health Products Revenue (2021-2032)
1.3.8 India Based Company NAD+ Health Products Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 NAD+ Health Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World NAD+ Health Products Consumption Value (2021-2032)
2.2 World NAD+ Health Products Consumption Value by Region
2.2.1 World NAD+ Health Products Consumption Value by Region (2021-2026)
2.2.2 World NAD+ Health Products Consumption Value Forecast by Region (2027-2032)
2.3 United States NAD+ Health Products Consumption Value (2021-2032)
2.4 China NAD+ Health Products Consumption Value (2021-2032)
2.5 Europe NAD+ Health Products Consumption Value (2021-2032)
2.6 Japan NAD+ Health Products Consumption Value (2021-2032)
2.7 South Korea NAD+ Health Products Consumption Value (2021-2032)
2.8 ASEAN NAD+ Health Products Consumption Value (2021-2032)
2.9 India NAD+ Health Products Consumption Value (2021-2032)
3 WORLD NAD+ HEALTH PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World NAD+ Health Products Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NAD+ Health Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NAD+ Health Products in 2025
3.2.3 Global Concentration Ratios (CR8) for NAD+ Health Products in 2025
3.3 NAD+ Health Products Company Evaluation Quadrant
3.4 NAD+ Health Products Market: Overall Company Footprint Analysis
3.4.1 NAD+ Health Products Market: Region Footprint
3.4.2 NAD+ Health Products Market: Company Product Type Footprint
3.4.3 NAD+ Health Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NAD+ Health Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NAD+ Health Products Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: NAD+ Health Products Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: NAD+ Health Products Consumption Value Comparison
4.2.1 United States VS China: NAD+ Health Products Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: NAD+ Health Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based NAD+ Health Products Companies and Market Share, 2021-2026
4.3.1 United States Based NAD+ Health Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NAD+ Health Products Revenue, (2021-2026)
4.4 China Based Companies NAD+ Health Products Revenue and Market Share, 2021-2026
4.4.1 China Based NAD+ Health Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NAD+ Health Products Revenue, (2021-2026)
4.5 Rest of World Based NAD+ Health Products Companies and Market Share, 2021-2026
4.5.1 Rest of World Based NAD+ Health Products Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies NAD+ Health Products Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World NAD+ Health Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 NMNContent ?98%
5.2.2 NMNContent ?98%
5.3 Market Segment by Type
5.3.1 World NAD+ Health Products Market Size by Type (2021-2026)
5.3.2 World NAD+ Health Products Market Size by Type (2027-2032)
5.3.3 World NAD+ Health Products Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY FORM
6.1 World NAD+ Health Products Market Size Overview by Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Form
6.2.1 Powder
6.2.2 Liquid
6.2.3 Others
6.3 Market Segment by Form
6.3.1 World NAD+ Health Products Market Size by Form (2021-2026)
6.3.2 World NAD+ Health Products Market Size by Form (2027-2032)
6.3.3 World NAD+ Health Products Market Size Market Share by Form (2027-2032)
7 MARKET ANALYSIS BY INGESTION METHOD
7.1 World NAD+ Health Products Market Size Overview by Ingestion Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Ingestion Method
7.2.1 Oral Type
7.2.2 Non-oral Type
7.3 Market Segment by Ingestion Method
7.3.1 World NAD+ Health Products Market Size by Ingestion Method (2021-2026)
7.3.2 World NAD+ Health Products Market Size by Ingestion Method (2027-2032)
7.3.3 World NAD+ Health Products Market Size Market Share by Ingestion Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World NAD+ Health Products Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Health Care Products
8.2.2 Beauty Products
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World NAD+ Health Products Market Size by Application (2021-2026)
8.3.2 World NAD+ Health Products Market Size by Application (2027-2032)
8.3.3 World NAD+ Health Products Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GeneHarbor
9.1.1 GeneHarbor Details
9.1.2 GeneHarbor Major Business
9.1.3 GeneHarbor NAD+ Health Products Product and Services
9.1.4 GeneHarbor NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GeneHarbor Recent Developments/Updates
9.1.6 GeneHarbor Competitive Strengths & Weaknesses
9.2 Niagen Bioscience
9.2.1 Niagen Bioscience Details
9.2.2 Niagen Bioscience Major Business
9.2.3 Niagen Bioscience NAD+ Health Products Product and Services
9.2.4 Niagen Bioscience NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Niagen Bioscience Recent Developments/Updates
9.2.6 Niagen Bioscience Competitive Strengths & Weaknesses
9.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
9.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Details
9.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Major Business
9.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product and Services
9.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates
9.3.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Competitive Strengths & Weaknesses
9.4 Herbalmax
9.4.1 Herbalmax Details
9.4.2 Herbalmax Major Business
9.4.3 Herbalmax NAD+ Health Products Product and Services
9.4.4 Herbalmax NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Herbalmax Recent Developments/Updates
9.4.6 Herbalmax Competitive Strengths & Weaknesses
9.5 EffePharm
9.5.1 EffePharm Details
9.5.2 EffePharm Major Business
9.5.3 EffePharm NAD+ Health Products Product and Services
9.5.4 EffePharm NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EffePharm Recent Developments/Updates
9.5.6 EffePharm Competitive Strengths & Weaknesses
9.6 Kingdomway
9.6.1 Kingdomway Details
9.6.2 Kingdomway Major Business
9.6.3 Kingdomway NAD+ Health Products Product and Services
9.6.4 Kingdomway NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Kingdomway Recent Developments/Updates
9.6.6 Kingdomway Competitive Strengths & Weaknesses
9.7 NOMON Co., Ltd. (Teijin)
9.7.1 NOMON Co., Ltd. (Teijin) Details
9.7.2 NOMON Co., Ltd. (Teijin) Major Business
9.7.3 NOMON Co., Ltd. (Teijin) NAD+ Health Products Product and Services
9.7.4 NOMON Co., Ltd. (Teijin) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NOMON Co., Ltd. (Teijin) Recent Developments/Updates
9.7.6 NOMON Co., Ltd. (Teijin) Competitive Strengths & Weaknesses
9.8 CELFULL
9.8.1 CELFULL Details
9.8.2 CELFULL Major Business
9.8.3 CELFULL NAD+ Health Products Product and Services
9.8.4 CELFULL NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 CELFULL Recent Developments/Updates
9.8.6 CELFULL Competitive Strengths & Weaknesses
9.9 Bontac
9.9.1 Bontac Details
9.9.2 Bontac Major Business
9.9.3 Bontac NAD+ Health Products Product and Services
9.9.4 Bontac NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Bontac Recent Developments/Updates
9.9.6 Bontac Competitive Strengths & Weaknesses
9.10 Genex Formulas
9.10.1 Genex Formulas Details
9.10.2 Genex Formulas Major Business
9.10.3 Genex Formulas NAD+ Health Products Product and Services
9.10.4 Genex Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Genex Formulas Recent Developments/Updates
9.10.6 Genex Formulas Competitive Strengths & Weaknesses
9.11 EZZ
9.11.1 EZZ Details
9.11.2 EZZ Major Business
9.11.3 EZZ NAD+ Health Products Product and Services
9.11.4 EZZ NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 EZZ Recent Developments/Updates
9.11.6 EZZ Competitive Strengths & Weaknesses
9.12 Maac10 Formulas
9.12.1 Maac10 Formulas Details
9.12.2 Maac10 Formulas Major Business
9.12.3 Maac10 Formulas NAD+ Health Products Product and Services
9.12.4 Maac10 Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Maac10 Formulas Recent Developments/Updates
9.12.6 Maac10 Formulas Competitive Strengths & Weaknesses
9.13 Elysium Health
9.13.1 Elysium Health Details
9.13.2 Elysium Health Major Business
9.13.3 Elysium Health NAD+ Health Products Product and Services
9.13.4 Elysium Health NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Elysium Health Recent Developments/Updates
9.13.6 Elysium Health Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 NAD+ Health Products Industry Chain
10.2 NAD+ Health Products Upstream Analysis
10.3 NAD+ Health Products Midstream Analysis
10.4 NAD+ Health Products Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 NAD+ Health Products Introduction
1.2 World NAD+ Health Products Market Size & Forecast (2021 & 2025 & 2032)
1.3 World NAD+ Health Products Total Market by Region (by Headquarter Location)
1.3.1 World NAD+ Health Products Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company NAD+ Health Products Revenue (2021-2032)
1.3.3 China Based Company NAD+ Health Products Revenue (2021-2032)
1.3.4 Europe Based Company NAD+ Health Products Revenue (2021-2032)
1.3.5 Japan Based Company NAD+ Health Products Revenue (2021-2032)
1.3.6 South Korea Based Company NAD+ Health Products Revenue (2021-2032)
1.3.7 ASEAN Based Company NAD+ Health Products Revenue (2021-2032)
1.3.8 India Based Company NAD+ Health Products Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 NAD+ Health Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World NAD+ Health Products Consumption Value (2021-2032)
2.2 World NAD+ Health Products Consumption Value by Region
2.2.1 World NAD+ Health Products Consumption Value by Region (2021-2026)
2.2.2 World NAD+ Health Products Consumption Value Forecast by Region (2027-2032)
2.3 United States NAD+ Health Products Consumption Value (2021-2032)
2.4 China NAD+ Health Products Consumption Value (2021-2032)
2.5 Europe NAD+ Health Products Consumption Value (2021-2032)
2.6 Japan NAD+ Health Products Consumption Value (2021-2032)
2.7 South Korea NAD+ Health Products Consumption Value (2021-2032)
2.8 ASEAN NAD+ Health Products Consumption Value (2021-2032)
2.9 India NAD+ Health Products Consumption Value (2021-2032)
3 WORLD NAD+ HEALTH PRODUCTS COMPANIES COMPETITIVE ANALYSIS
3.1 World NAD+ Health Products Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NAD+ Health Products Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NAD+ Health Products in 2025
3.2.3 Global Concentration Ratios (CR8) for NAD+ Health Products in 2025
3.3 NAD+ Health Products Company Evaluation Quadrant
3.4 NAD+ Health Products Market: Overall Company Footprint Analysis
3.4.1 NAD+ Health Products Market: Region Footprint
3.4.2 NAD+ Health Products Market: Company Product Type Footprint
3.4.3 NAD+ Health Products Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NAD+ Health Products Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NAD+ Health Products Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: NAD+ Health Products Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: NAD+ Health Products Consumption Value Comparison
4.2.1 United States VS China: NAD+ Health Products Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: NAD+ Health Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based NAD+ Health Products Companies and Market Share, 2021-2026
4.3.1 United States Based NAD+ Health Products Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NAD+ Health Products Revenue, (2021-2026)
4.4 China Based Companies NAD+ Health Products Revenue and Market Share, 2021-2026
4.4.1 China Based NAD+ Health Products Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NAD+ Health Products Revenue, (2021-2026)
4.5 Rest of World Based NAD+ Health Products Companies and Market Share, 2021-2026
4.5.1 Rest of World Based NAD+ Health Products Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies NAD+ Health Products Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World NAD+ Health Products Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 NMNContent ?98%
5.2.2 NMNContent ?98%
5.3 Market Segment by Type
5.3.1 World NAD+ Health Products Market Size by Type (2021-2026)
5.3.2 World NAD+ Health Products Market Size by Type (2027-2032)
5.3.3 World NAD+ Health Products Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY FORM
6.1 World NAD+ Health Products Market Size Overview by Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Form
6.2.1 Powder
6.2.2 Liquid
6.2.3 Others
6.3 Market Segment by Form
6.3.1 World NAD+ Health Products Market Size by Form (2021-2026)
6.3.2 World NAD+ Health Products Market Size by Form (2027-2032)
6.3.3 World NAD+ Health Products Market Size Market Share by Form (2027-2032)
7 MARKET ANALYSIS BY INGESTION METHOD
7.1 World NAD+ Health Products Market Size Overview by Ingestion Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Ingestion Method
7.2.1 Oral Type
7.2.2 Non-oral Type
7.3 Market Segment by Ingestion Method
7.3.1 World NAD+ Health Products Market Size by Ingestion Method (2021-2026)
7.3.2 World NAD+ Health Products Market Size by Ingestion Method (2027-2032)
7.3.3 World NAD+ Health Products Market Size Market Share by Ingestion Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World NAD+ Health Products Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Health Care Products
8.2.2 Beauty Products
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World NAD+ Health Products Market Size by Application (2021-2026)
8.3.2 World NAD+ Health Products Market Size by Application (2027-2032)
8.3.3 World NAD+ Health Products Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GeneHarbor
9.1.1 GeneHarbor Details
9.1.2 GeneHarbor Major Business
9.1.3 GeneHarbor NAD+ Health Products Product and Services
9.1.4 GeneHarbor NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GeneHarbor Recent Developments/Updates
9.1.6 GeneHarbor Competitive Strengths & Weaknesses
9.2 Niagen Bioscience
9.2.1 Niagen Bioscience Details
9.2.2 Niagen Bioscience Major Business
9.2.3 Niagen Bioscience NAD+ Health Products Product and Services
9.2.4 Niagen Bioscience NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Niagen Bioscience Recent Developments/Updates
9.2.6 Niagen Bioscience Competitive Strengths & Weaknesses
9.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
9.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Details
9.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Major Business
9.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product and Services
9.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates
9.3.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Competitive Strengths & Weaknesses
9.4 Herbalmax
9.4.1 Herbalmax Details
9.4.2 Herbalmax Major Business
9.4.3 Herbalmax NAD+ Health Products Product and Services
9.4.4 Herbalmax NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Herbalmax Recent Developments/Updates
9.4.6 Herbalmax Competitive Strengths & Weaknesses
9.5 EffePharm
9.5.1 EffePharm Details
9.5.2 EffePharm Major Business
9.5.3 EffePharm NAD+ Health Products Product and Services
9.5.4 EffePharm NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EffePharm Recent Developments/Updates
9.5.6 EffePharm Competitive Strengths & Weaknesses
9.6 Kingdomway
9.6.1 Kingdomway Details
9.6.2 Kingdomway Major Business
9.6.3 Kingdomway NAD+ Health Products Product and Services
9.6.4 Kingdomway NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Kingdomway Recent Developments/Updates
9.6.6 Kingdomway Competitive Strengths & Weaknesses
9.7 NOMON Co., Ltd. (Teijin)
9.7.1 NOMON Co., Ltd. (Teijin) Details
9.7.2 NOMON Co., Ltd. (Teijin) Major Business
9.7.3 NOMON Co., Ltd. (Teijin) NAD+ Health Products Product and Services
9.7.4 NOMON Co., Ltd. (Teijin) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NOMON Co., Ltd. (Teijin) Recent Developments/Updates
9.7.6 NOMON Co., Ltd. (Teijin) Competitive Strengths & Weaknesses
9.8 CELFULL
9.8.1 CELFULL Details
9.8.2 CELFULL Major Business
9.8.3 CELFULL NAD+ Health Products Product and Services
9.8.4 CELFULL NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 CELFULL Recent Developments/Updates
9.8.6 CELFULL Competitive Strengths & Weaknesses
9.9 Bontac
9.9.1 Bontac Details
9.9.2 Bontac Major Business
9.9.3 Bontac NAD+ Health Products Product and Services
9.9.4 Bontac NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Bontac Recent Developments/Updates
9.9.6 Bontac Competitive Strengths & Weaknesses
9.10 Genex Formulas
9.10.1 Genex Formulas Details
9.10.2 Genex Formulas Major Business
9.10.3 Genex Formulas NAD+ Health Products Product and Services
9.10.4 Genex Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Genex Formulas Recent Developments/Updates
9.10.6 Genex Formulas Competitive Strengths & Weaknesses
9.11 EZZ
9.11.1 EZZ Details
9.11.2 EZZ Major Business
9.11.3 EZZ NAD+ Health Products Product and Services
9.11.4 EZZ NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 EZZ Recent Developments/Updates
9.11.6 EZZ Competitive Strengths & Weaknesses
9.12 Maac10 Formulas
9.12.1 Maac10 Formulas Details
9.12.2 Maac10 Formulas Major Business
9.12.3 Maac10 Formulas NAD+ Health Products Product and Services
9.12.4 Maac10 Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Maac10 Formulas Recent Developments/Updates
9.12.6 Maac10 Formulas Competitive Strengths & Weaknesses
9.13 Elysium Health
9.13.1 Elysium Health Details
9.13.2 Elysium Health Major Business
9.13.3 Elysium Health NAD+ Health Products Product and Services
9.13.4 Elysium Health NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Elysium Health Recent Developments/Updates
9.13.6 Elysium Health Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 NAD+ Health Products Industry Chain
10.2 NAD+ Health Products Upstream Analysis
10.3 NAD+ Health Products Midstream Analysis
10.4 NAD+ Health Products Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World NAD+ Health Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World NAD+ Health Products Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World NAD+ Health Products Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World NAD+ Health Products Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World NAD+ Health Products Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NAD+ Health Products Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World NAD+ Health Products Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World NAD+ Health Products Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World NAD+ Health Products Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key NAD+ Health Products Players in 2025
Table 12. World NAD+ Health Products Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global NAD+ Health Products Company Evaluation Quadrant
Table 14. Head Office of Key NAD+ Health Products Players
Table 15. NAD+ Health Products Market: Company Product Type Footprint
Table 16. NAD+ Health Products Market: Company Product Application Footprint
Table 17. NAD+ Health Products Mergers & Acquisitions Activity
Table 18. United States VS China NAD+ Health Products Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China NAD+ Health Products Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based NAD+ Health Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies NAD+ Health Products Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 23. China Based NAD+ Health Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies NAD+ Health Products Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 26. Rest of World Based NAD+ Health Products Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies NAD+ Health Products Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 29. World NAD+ Health Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World NAD+ Health Products Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World NAD+ Health Products Market Size by Type (2027-2032) & (USD Million)
Table 32. World NAD+ Health Products Market Size by Form, (USD Million), 2021 & 2025 & 2032
Table 33. World NAD+ Health Products Market Size Value by Form (2021-2026) & (USD Million)
Table 34. World NAD+ Health Products Market Size by Form (2027-2032) & (USD Million)
Table 35. World NAD+ Health Products Market Size by Ingestion Method, (USD Million), 2021 & 2025 & 2032
Table 36. World NAD+ Health Products Market Size Value by Ingestion Method (2021-2026) & (USD Million)
Table 37. World NAD+ Health Products Market Size by Ingestion Method (2027-2032) & (USD Million)
Table 38. World NAD+ Health Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World NAD+ Health Products Market Size by Application (2021-2026) & (USD Million)
Table 40. World NAD+ Health Products Market Size by Application (2027-2032) & (USD Million)
Table 41. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 42. GeneHarbor Major Business
Table 43. GeneHarbor NAD+ Health Products Product and Services
Table 44. GeneHarbor NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GeneHarbor Recent Developments/Updates
Table 46. GeneHarbor Competitive Strengths & Weaknesses
Table 47. Niagen Bioscience Basic Information, Manufacturing Base and Competitors
Table 48. Niagen Bioscience Major Business
Table 49. Niagen Bioscience NAD+ Health Products Product and Services
Table 50. Niagen Bioscience NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Niagen Bioscience Recent Developments/Updates
Table 52. Niagen Bioscience Competitive Strengths & Weaknesses
Table 53. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 54. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Major Business
Table 55. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product and Services
Table 56. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates
Table 58. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Competitive Strengths & Weaknesses
Table 59. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 60. Herbalmax Major Business
Table 61. Herbalmax NAD+ Health Products Product and Services
Table 62. Herbalmax NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Herbalmax Recent Developments/Updates
Table 64. Herbalmax Competitive Strengths & Weaknesses
Table 65. EffePharm Basic Information, Manufacturing Base and Competitors
Table 66. EffePharm Major Business
Table 67. EffePharm NAD+ Health Products Product and Services
Table 68. EffePharm NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EffePharm Recent Developments/Updates
Table 70. EffePharm Competitive Strengths & Weaknesses
Table 71. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 72. Kingdomway Major Business
Table 73. Kingdomway NAD+ Health Products Product and Services
Table 74. Kingdomway NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Kingdomway Recent Developments/Updates
Table 76. Kingdomway Competitive Strengths & Weaknesses
Table 77. NOMON Co., Ltd. (Teijin) Basic Information, Manufacturing Base and Competitors
Table 78. NOMON Co., Ltd. (Teijin) Major Business
Table 79. NOMON Co., Ltd. (Teijin) NAD+ Health Products Product and Services
Table 80. NOMON Co., Ltd. (Teijin) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NOMON Co., Ltd. (Teijin) Recent Developments/Updates
Table 82. NOMON Co., Ltd. (Teijin) Competitive Strengths & Weaknesses
Table 83. CELFULL Basic Information, Manufacturing Base and Competitors
Table 84. CELFULL Major Business
Table 85. CELFULL NAD+ Health Products Product and Services
Table 86. CELFULL NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. CELFULL Recent Developments/Updates
Table 88. CELFULL Competitive Strengths & Weaknesses
Table 89. Bontac Basic Information, Manufacturing Base and Competitors
Table 90. Bontac Major Business
Table 91. Bontac NAD+ Health Products Product and Services
Table 92. Bontac NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Bontac Recent Developments/Updates
Table 94. Bontac Competitive Strengths & Weaknesses
Table 95. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 96. Genex Formulas Major Business
Table 97. Genex Formulas NAD+ Health Products Product and Services
Table 98. Genex Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Genex Formulas Recent Developments/Updates
Table 100. Genex Formulas Competitive Strengths & Weaknesses
Table 101. EZZ Basic Information, Manufacturing Base and Competitors
Table 102. EZZ Major Business
Table 103. EZZ NAD+ Health Products Product and Services
Table 104. EZZ NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. EZZ Recent Developments/Updates
Table 106. EZZ Competitive Strengths & Weaknesses
Table 107. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 108. Maac10 Formulas Major Business
Table 109. Maac10 Formulas NAD+ Health Products Product and Services
Table 110. Maac10 Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Maac10 Formulas Recent Developments/Updates
Table 112. Maac10 Formulas Competitive Strengths & Weaknesses
Table 113. Elysium Health Basic Information, Manufacturing Base and Competitors
Table 114. Elysium Health Major Business
Table 115. Elysium Health NAD+ Health Products Product and Services
Table 116. Elysium Health NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Elysium Health Recent Developments/Updates
Table 118. Elysium Health Competitive Strengths & Weaknesses
Table 119. Global Key Players of NAD+ Health Products Upstream (Raw Materials)
Table 120. Global NAD+ Health Products Typical Customers
Table 1. World NAD+ Health Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World NAD+ Health Products Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World NAD+ Health Products Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World NAD+ Health Products Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World NAD+ Health Products Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NAD+ Health Products Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World NAD+ Health Products Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World NAD+ Health Products Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World NAD+ Health Products Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key NAD+ Health Products Players in 2025
Table 12. World NAD+ Health Products Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global NAD+ Health Products Company Evaluation Quadrant
Table 14. Head Office of Key NAD+ Health Products Players
Table 15. NAD+ Health Products Market: Company Product Type Footprint
Table 16. NAD+ Health Products Market: Company Product Application Footprint
Table 17. NAD+ Health Products Mergers & Acquisitions Activity
Table 18. United States VS China NAD+ Health Products Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China NAD+ Health Products Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based NAD+ Health Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies NAD+ Health Products Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 23. China Based NAD+ Health Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies NAD+ Health Products Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 26. Rest of World Based NAD+ Health Products Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies NAD+ Health Products Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies NAD+ Health Products Revenue Market Share (2021-2026)
Table 29. World NAD+ Health Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World NAD+ Health Products Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World NAD+ Health Products Market Size by Type (2027-2032) & (USD Million)
Table 32. World NAD+ Health Products Market Size by Form, (USD Million), 2021 & 2025 & 2032
Table 33. World NAD+ Health Products Market Size Value by Form (2021-2026) & (USD Million)
Table 34. World NAD+ Health Products Market Size by Form (2027-2032) & (USD Million)
Table 35. World NAD+ Health Products Market Size by Ingestion Method, (USD Million), 2021 & 2025 & 2032
Table 36. World NAD+ Health Products Market Size Value by Ingestion Method (2021-2026) & (USD Million)
Table 37. World NAD+ Health Products Market Size by Ingestion Method (2027-2032) & (USD Million)
Table 38. World NAD+ Health Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World NAD+ Health Products Market Size by Application (2021-2026) & (USD Million)
Table 40. World NAD+ Health Products Market Size by Application (2027-2032) & (USD Million)
Table 41. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 42. GeneHarbor Major Business
Table 43. GeneHarbor NAD+ Health Products Product and Services
Table 44. GeneHarbor NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GeneHarbor Recent Developments/Updates
Table 46. GeneHarbor Competitive Strengths & Weaknesses
Table 47. Niagen Bioscience Basic Information, Manufacturing Base and Competitors
Table 48. Niagen Bioscience Major Business
Table 49. Niagen Bioscience NAD+ Health Products Product and Services
Table 50. Niagen Bioscience NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Niagen Bioscience Recent Developments/Updates
Table 52. Niagen Bioscience Competitive Strengths & Weaknesses
Table 53. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 54. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Major Business
Table 55. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product and Services
Table 56. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates
Table 58. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Competitive Strengths & Weaknesses
Table 59. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 60. Herbalmax Major Business
Table 61. Herbalmax NAD+ Health Products Product and Services
Table 62. Herbalmax NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Herbalmax Recent Developments/Updates
Table 64. Herbalmax Competitive Strengths & Weaknesses
Table 65. EffePharm Basic Information, Manufacturing Base and Competitors
Table 66. EffePharm Major Business
Table 67. EffePharm NAD+ Health Products Product and Services
Table 68. EffePharm NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EffePharm Recent Developments/Updates
Table 70. EffePharm Competitive Strengths & Weaknesses
Table 71. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 72. Kingdomway Major Business
Table 73. Kingdomway NAD+ Health Products Product and Services
Table 74. Kingdomway NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Kingdomway Recent Developments/Updates
Table 76. Kingdomway Competitive Strengths & Weaknesses
Table 77. NOMON Co., Ltd. (Teijin) Basic Information, Manufacturing Base and Competitors
Table 78. NOMON Co., Ltd. (Teijin) Major Business
Table 79. NOMON Co., Ltd. (Teijin) NAD+ Health Products Product and Services
Table 80. NOMON Co., Ltd. (Teijin) NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NOMON Co., Ltd. (Teijin) Recent Developments/Updates
Table 82. NOMON Co., Ltd. (Teijin) Competitive Strengths & Weaknesses
Table 83. CELFULL Basic Information, Manufacturing Base and Competitors
Table 84. CELFULL Major Business
Table 85. CELFULL NAD+ Health Products Product and Services
Table 86. CELFULL NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. CELFULL Recent Developments/Updates
Table 88. CELFULL Competitive Strengths & Weaknesses
Table 89. Bontac Basic Information, Manufacturing Base and Competitors
Table 90. Bontac Major Business
Table 91. Bontac NAD+ Health Products Product and Services
Table 92. Bontac NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Bontac Recent Developments/Updates
Table 94. Bontac Competitive Strengths & Weaknesses
Table 95. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 96. Genex Formulas Major Business
Table 97. Genex Formulas NAD+ Health Products Product and Services
Table 98. Genex Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Genex Formulas Recent Developments/Updates
Table 100. Genex Formulas Competitive Strengths & Weaknesses
Table 101. EZZ Basic Information, Manufacturing Base and Competitors
Table 102. EZZ Major Business
Table 103. EZZ NAD+ Health Products Product and Services
Table 104. EZZ NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. EZZ Recent Developments/Updates
Table 106. EZZ Competitive Strengths & Weaknesses
Table 107. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 108. Maac10 Formulas Major Business
Table 109. Maac10 Formulas NAD+ Health Products Product and Services
Table 110. Maac10 Formulas NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Maac10 Formulas Recent Developments/Updates
Table 112. Maac10 Formulas Competitive Strengths & Weaknesses
Table 113. Elysium Health Basic Information, Manufacturing Base and Competitors
Table 114. Elysium Health Major Business
Table 115. Elysium Health NAD+ Health Products Product and Services
Table 116. Elysium Health NAD+ Health Products Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Elysium Health Recent Developments/Updates
Table 118. Elysium Health Competitive Strengths & Weaknesses
Table 119. Global Key Players of NAD+ Health Products Upstream (Raw Materials)
Table 120. Global NAD+ Health Products Typical Customers
LIST OF FIGURES
Figure 1. NAD+ Health Products Picture
Figure 2. World NAD+ Health Products Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World NAD+ Health Products Total Revenue (2021-2032) & (USD Million)
Figure 4. World NAD+ Health Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World NAD+ Health Products Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 13. NAD+ Health Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 16. World NAD+ Health Products Consumption Value Market Share by Region (2021-2032)
Figure 17. United States NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 18. China NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 23. India NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of NAD+ Health Products by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for NAD+ Health Products Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for NAD+ Health Products Markets in 2025
Figure 27. United States VS China: NAD+ Health Products Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: NAD+ Health Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World NAD+ Health Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World NAD+ Health Products Market Size Market Share by Type in 2025
Figure 31. NMNContent ?98%
Figure 32. NMNContent ?98%
Figure 33. World NAD+ Health Products Market Size Market Share by Type (2021-2032)
Figure 34. World NAD+ Health Products Market Size by Form, (USD Million), 2021 & 2025 & 2032
Figure 35. World NAD+ Health Products Market Size Market Share by Form in 2025
Figure 36. Powder
Figure 37. Liquid
Figure 38. Others
Figure 39. World NAD+ Health Products Market Size Market Share by Form (2021-2032)
Figure 40. World NAD+ Health Products Market Size by Ingestion Method, (USD Million), 2021 & 2025 & 2032
Figure 41. World NAD+ Health Products Market Size Market Share by Ingestion Method in 2025
Figure 42. Oral Type
Figure 43. Non-oral Type
Figure 44. World NAD+ Health Products Market Size Market Share by Ingestion Method (2021-2032)
Figure 45. World NAD+ Health Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World NAD+ Health Products Market Size Market Share by Application in 2025
Figure 47. Health Care Products
Figure 48. Beauty Products
Figure 49. Others
Figure 50. World NAD+ Health Products Market Size Market Share by Application (2021-2032)
Figure 51. NAD+ Health Products Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. NAD+ Health Products Picture
Figure 2. World NAD+ Health Products Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World NAD+ Health Products Total Revenue (2021-2032) & (USD Million)
Figure 4. World NAD+ Health Products Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World NAD+ Health Products Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company NAD+ Health Products Revenue (2021-2032) & (USD Million)
Figure 13. NAD+ Health Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 16. World NAD+ Health Products Consumption Value Market Share by Region (2021-2032)
Figure 17. United States NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 18. China NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 23. India NAD+ Health Products Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of NAD+ Health Products by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for NAD+ Health Products Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for NAD+ Health Products Markets in 2025
Figure 27. United States VS China: NAD+ Health Products Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: NAD+ Health Products Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World NAD+ Health Products Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World NAD+ Health Products Market Size Market Share by Type in 2025
Figure 31. NMNContent ?98%
Figure 32. NMNContent ?98%
Figure 33. World NAD+ Health Products Market Size Market Share by Type (2021-2032)
Figure 34. World NAD+ Health Products Market Size by Form, (USD Million), 2021 & 2025 & 2032
Figure 35. World NAD+ Health Products Market Size Market Share by Form in 2025
Figure 36. Powder
Figure 37. Liquid
Figure 38. Others
Figure 39. World NAD+ Health Products Market Size Market Share by Form (2021-2032)
Figure 40. World NAD+ Health Products Market Size by Ingestion Method, (USD Million), 2021 & 2025 & 2032
Figure 41. World NAD+ Health Products Market Size Market Share by Ingestion Method in 2025
Figure 42. Oral Type
Figure 43. Non-oral Type
Figure 44. World NAD+ Health Products Market Size Market Share by Ingestion Method (2021-2032)
Figure 45. World NAD+ Health Products Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World NAD+ Health Products Market Size Market Share by Application in 2025
Figure 47. Health Care Products
Figure 48. Beauty Products
Figure 49. Others
Figure 50. World NAD+ Health Products Market Size Market Share by Application (2021-2032)
Figure 51. NAD+ Health Products Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
